Exploring the therapeutic potential of marine actinomycetes: a systems biology-based approach for Alzheimer’s disease treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploring the therapeutic potential of marine actinomycetes: a systems biology-based approach for Alzheimer’s disease treatment ; volume:1 ; number:1 ; day:11 ; month:11 ; year:2024 ; pages:1-20 ; date:12.2024
Discover molecules ; 1, Heft 1 (11.11.2024), 1-20, 12.2024
- Creator
-
Chowdhury, Mayank Roy
Kizhakedathil, Moni Philip Jacob
Kumar, Vinith
Saktheeswaran, M.
Mathesh, K. Kutty
Deepa, Vijaykumar Sudarshana
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s44345-024-00004-6
- URN
-
urn:nbn:de:101:1-2501282131567.794716815797
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chowdhury, Mayank Roy
- Kizhakedathil, Moni Philip Jacob
- Kumar, Vinith
- Saktheeswaran, M.
- Mathesh, K. Kutty
- Deepa, Vijaykumar Sudarshana
- SpringerLink (Online service)
Other Objects (12)
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Alzheimer disease : therapeutic strategies
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Mapping Alzheimer’s disease: exploring cellular vulnerability and resilience
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Alzheimer disease : therapeutic strategies
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Mapping Alzheimer’s disease: exploring cellular vulnerability and resilience
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Alzheimer disease : therapeutic strategies
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Mapping Alzheimer’s disease: exploring cellular vulnerability and resilience
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease